Prevalence of multiple sclerosis in Canada: A systematic review

Canadian Journal of Neurological Sciences

Volumn 35, Issue 5, 2008, Pages 593-601

  Poppe, Alexandre Y ^b   Wolfson, Christina ^a   Zhu, Bin ^a  

^a MCGILL UNIVERSITY   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANADA; DATA EXTRACTION; EMBASE; GEOGRAPHIC DISTRIBUTION; HUMAN; LATITUDE; LONGITUDE; MEDLINE; MULTIPLE SCLEROSIS; POPULATION RISK; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; REGISTER; REVIEW; SYSTEMATIC REVIEW;

EID: 57849084401     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100009380     Document Type: Review

References (47)

1. Poser CM. The epidemiology of multiple sclerosis: a general overview. Ann Neurol. 1994 Dec;36 Suppl 2:S180-93.
2. Poser CM. The diagnosis and management of multiple sclerosis. Acta Neurol Scand. 2005 Sep;112(3):199-201.
3. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci. 2001 Apr;22(2):117-39.
4. Hader WJ, Elliot M, Ebers GC. Epidemiology of multiple sclerosis in London and Middlesex County, Ontario, Canada. Neurology. 1988 Apr;38(4):617-21.
5. Sloka JS, Pryse-Phillips WE, Stefanelli M. Incidence and prevalence of multiple sclerosis in Newfoundland and Labrador. Can J Neurol Sci. 2005 Feb;32(1):37-42.
6. Pryse-Phillips WE. The incidence and prevalence of multiple sclerosis in Newfoundland and Labrador, 1960-1984. Ann Neurol. 1986 Sep;20(3):323-8.
7. Hader W. The incidence and prevalence of multiple sclerosis in Saskatoon, Saskatchewan: a reappraisal. Neuroepidemiology. 1999;18:327-32.
8. Bhan V, Brown MG, Fisk JD, Sketris I, Stadnyk K, MacKinnon-Cameron D, Li N. Incidence and prevalence of Multiple Sclerosis in Nova Scotia. American Academy of Neurology Annual Meeting, miami, Florida, April 14, 2005. Neurology. 2005; 64 Suppl 1: A320.
9. Warren S, Warren KG. Prevalence of multiple sclerosis in Barrhead County, Alberta, Canada. Can J Neurol Sci. 1992 Feb;19(1): 72-5.
10. Sweeney VP, Sadovnick AD, Brandejs V. Prevalence of multiple sclerosis in British Columbia. Can J Neurol Sci. 1986 Feb;13 (1):47-51.
11. Klein GM, Rose MS, Seland TP. A prevalence study of multiple sclerosis in the Crowsnest Pass region of southern Alberta. Can J Neurol Sci. 1994 Aug;21(3):262-5.
12. Warren S, Warren KG. Prevalence, incidence, and characteristics of multiple sclerosis in Westlock County, Alberta, Canada. Neurology. 1993 Sep;43(9):1760-3.
13. Beck CA, Metz LM, Svenson LW, Patten SB. Regional variation of multiple sclerosis prevalence in Canada. Mult Scler. 2005 Oct;11(5):516-9.
14. Svenson LW, Woodhead SE, Platt GH. Regional variations in the prevalence rates of multiple sclerosis in the province of Alberta, Canada. Neuroepidemiology. 1994;13(1-2):8-13.
15. Hader WJ LI. Incidence and prevalence of multiple sclerosis in Saskatoon, Saskatchewan. Neurology. 2007;69:1224-9.
16. 2006 Census. Statistics Canada; 2007.
17. Hader W, Feasby T, Rice GPA, Ebers G. Multiple sclerosis in Canadian native peoples. Neurology. 1985;35Suppl 1:300.
18. Mirsattari SM, Johnston JB, McKenna R, Del Bigio MR, Orr P, Ross RT, et al. Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optiea. Neurology. 2001 Feb 13;56(3):317-23.
19. Warren S, Svenson LW, Warren KG, Metz LM, Patten SB, Schopflocher DP. Incidence of Multiple Sclerosis amound First Nation People in Alberta, Canada. Society for Epidemiologic Research, Toronto, Ontario, June 2005.
20. Warren S SL, Warren KG, Metz LM, Patten SB, Schopflocher DP. Prevalence of multiple sclerosis in First Nations people of Alberta. Can J Neurol Sci. 2007;34(2):175-80.
21. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of observational studies in epidemiology (MOOSE) group. JAMA. 2000 Apr 19;283 (15):2008-12.
22. Lemeshow AR, Blum RE, Berlin JA, Stoto MA, Colditz GA. Searching one or two databases was insufficient for meta-analysis of observational studies. J Clin Epidemiol. 2005 Sep;58(9):867-73.
23. Westlund KB, Kurland LT. Studies on multiple sclerosis in Winnipeg, Manitoba, and New Orleans, Louisiana. I. Prevalence; comparison between the patient groups in Winnipeg and New Orleans. Am J Hyg. 1953 May;57(3):380-96.
24. White DN, Wheelan L. Disseminated sclerosis; a survey of patients in the Kingston, Ontario, area. Neurology. 1959 Apr;9(4): 256-72.
25. Alter M, Talbert OR, Allison RS, Kurland LT. The geographic distribution of multiple sclerosis. A comparative study in Charleston County, South Carolina and Halifax County, Nova Scotia. I. Prevalence in Charleston County, South Carolina. J S C Med Assoc. 1960 Jun;56:209-13.
26. Stazio A, Kurland LT, Bell LG, Saunders MG, Rogot E. Multiple sclerosis in Winnipeg, Manitoba: methodological considerations of epidemiologic survey. ten year follow-up of a community wide study, and population re-survey. J Chronic Dis. 1964 May;17:415-38.
27. Bennett L, Hamilton R, Neutel CI, Pearson JC, Talbot B. Survey of persons with multiple sclerosis in Ottawa, 1974-75. Can J Public Health. 1977 Mar-Apr;68(2):141-7.
28. Hader WJ. Prevalence of multiple sclerosis in Saskatoon. Can Med Assoc J. 1982 Aug 15;127(4):295-7.
29. Dyment DA, Willer CJ, Scott B, Armstrong H, Ligers A, Hillert J, Paty DW, et al. Genetic susceptibility to MS: a second stage analysis in Canadian MS families. Neurogenetics. 2001;3(3):145-51.
30. Willer CJ, Dyment DA, Risch NJ, Sadovnick AD, Ebers GC, Canadian Collaborative Study Group. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci U S A. 2003;100(22):12877-82.
31. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003 Sep 6;327(7414): 557-60.
32. Hatala R, Keitz S, Wyer P, Guyatt G. Tips for learners of evidence-based medicine: 4. Assessing heterogeneity of primary studies in systematic reviews and whether to combine their results. CMAJ. 2005 Mar 1;172(5):661-5.
33. Cowen JB, Sjostrom BF, Doughty AS, Schiffer RB. Case-finding for MS prevalence studies in small communities requires a community-based approach. Neuroepidemiology. 2007;28:246-52.
34. Fangerau T, Schimrigk S, Haupts M, Kaeder M, Ahle G, Brune N, Klinkenberg K, et al. Diagnosis of multiple sclerosis: comparison of the Poser criteria and the new McDonald criteria. Acta Neurol Scand. 2004;109(6):385-89.
35. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol. 2005 Dec;58(6):840-6.
36. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001 Jul;50(1): 121-7.
37. Zivadinov R, Iona L, Monti-Bragadin L, Bosco A, Jurjevic A, Taus C, et al. The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study. Neuroepidemiology. 2003 Jan-Feb;22(1):65-74.
38. Hader WJ, Irvine DG, Schiefer HB. A cluster-focus of multiple sclerosis at Henribourg, Saskatchewan. Can J Neurol Sci. 1990 Nov;17(4):391-4.
39. Orton SM, Herrera BM, Yee IM, Valdar W, Ramagopalan SV, Sadovnick AD, Ebers GC. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol. 2007;5:932-6.
40. Sadovnick AD, Risch NJ, Ebers GC. Canadian collaborative project on genetic susceptibility to MS, phase 2: rationale and method. Can J Neurol Sci. 1998;25:216-21.
41. Warren S, Svenson L, Woodhead S, Warren KG. Parental ancestry and risk of multiple sclerosis in Alberta, Canada. Neuroepidemiology. 1996 Jan-Feb;15(1):1-9.
42. Hostetler J. The Hutterite Society. Baltimore: Johns Hopkins University; 1974.
43. Compston A. Genetic susceptibility to multiple sclerosis. In: Compston A, Ebers G, Lassman H, McDonald I, Matthews B, Werkerle H, editors. McAlpines multiple sclerosis. Edinburgh: Churchill-Livingston; 1998. p. 101-42.
44. Pugliatti M, Rosati G, Carton H, Riise T, Drulovic J, Vecsei L, Milanov I. The epidemiology of multiple sclerosis in Europe. Eur J Neurol. 2006;13:700-22.
45. Vukusic S, Van Bockstael V, Gosselin S, Confavreux C. Regional variations in the prevalence of multiple sclerosis in French farmers. J Neurol Neurosurg Psychiatry. 2007;78:707-9.
46. Coo H, Aronson KJ. A systematic review of several potential non-genetic risk factors for multiple sclerosis. Neuroepidemiology. 2004; 23:1-12.
47. Myhr KM, Grytten N, Aarseth JH, Nyland H. The Norwegian Multiple Sclerosis National Competence Centre and National Multiple Sclerosis registry - a resource for clinical practice and research. Acta Neurol Scan. 2006;183:Suppl. 37-40.